Within GVS’s global Transfusion Medicine network, the Covina site plays a strategic and operationally critical role, serving as a key manufacturing hub for North America while supporting global supply and quality standards.
Covina specializes in essential pharmaceutical manufacturing processes, including solution mixing, filling, sterilization and finishing. These activities represent some of the most critical steps in the transfusion medicine value chain, directly impacting product safety, consistency and regulatory compliance. Through close coordination with GVS manufacturing operations in Mexico, the site also supports a vertically integrated and resilient supply structure, ensuring continuity and reliability across markets.
Experience, regulatory expertise and proximity to the US market
One of Covina’s key strengths is its long‑standing experience in transfusion medicine. Active in this field for many years, the site benefits from deep practical knowledge across manufacturing, quality and regulatory requirements, an essential asset in a highly regulated environment. Its proximity to the US market and key customers further strengthens this role, enabling close alignment with customer needs, regulatory expectations and market dynamics, while supporting responsiveness and strong collaboration with partners.
Creating value through quality and collaboration
Covina creates value for GVS Transfusion Medicine by managing complex pharmaceutical processes while maintaining consistent quality standards. Beyond manufacturing execution, the site plays an important role in ensuring product consistency, process alignment and business continuity across the TM network. Working as one global Transfusion Medicine team, Covina is deeply integrated within the global network, with continuous collaboration across regions, particularly with teams in Mexico and other TM locations, to address evolving industry demands around quality, regulation and supply chain reliability.
People at the heart of the hub
People are a defining element of Covina’s strategic importance. Many team members bring long‑standing experience in transfusion medicine, contributing dedication, know‑how and a strong quality culture that supports both operational excellence and knowledge sharing across the global network.
Looking ahead
As industry expectations around quality, compliance and supply stability continue to grow, Covina is well positioned to support future development. The site is expected to remain a key manufacturing and technology hub, contributing to growth through strong processes, collaboration and potential future product transfers and innovation
